FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Product Patent Rights claiming compounds in the Pfizer Compound Library or Licensed Products, Pfizer shall have those rights and duties ascribed to Rigel in Section 6.1, except that Pfizer will bear all related expenses.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Pfizer Patent Rights and Patent Rights claiming Joint Technology, Pfizer shall have those rights and duties ascribed to Myco in Section 7.1
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Patent Rights in which Pfizer employees or consultants alone are named as inventors, Pfizer shall have those rights and duties ascribed to Megabios in Section 7.1.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Patent Rights claiming Pfizer Technology ("Pfizer Patent Rights") and Patent Rights claiming Joint Technology ("Joint Patent Rights"), Pfizer shall have those rights and duties ascribed to Myco in Section 6.1.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Patent Rights in which Pfizer employees or consultants alone are named as inventors, Pfizer shall have those rights and duties ascribed to Mitokor in Section 6.1., except that Pfizer will bear all related expenses.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Patent Rights in which Pfizer employees or consultants alone are named as inventors, Pfizer shall have those rights and duties ascribed to Microcide in Section 7. 1; provided, Microcide shall have no obligation to reimburse Pfizer for the payment of any expenses incurred in connection with such Patent Rights.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Program Technology, Pfizer (using in-house or outside counsel, at its discretion) shall have the exclusive right and obligation:
(a) to file applications for letters patent on any invention deemed patentable included in the Program Technology; provided, however, that Pfizer shall consult with Isis as to the countries in which such patent applications should be filed;
(b) to take all reasonable steps to prosecute all pending and new patent applications included within Program Technology Patent Rights;
(c) to respond to oppositions, nullity actions, re-examinations, revocation actions and similar proceedings filed by third parties against the grant of letters patent for such applications;
(d) to maintain in force any letters patent included in Program Technology Patent Rights by duly filing all necessary papers and paying any fees required by the patent laws of the particular country in which such letters patent were granted; and Isis shall cooperate fully with, and take all necessary actions requested by, Pfizer in connection with the preparation, prosecution and maintenance of any letters patent included in Program Technology Patent Rights. Pfizer will reimburse Isis for reasonable expenses incurred for personnel travel and time spent out of office in connection with the foregoing.
(e) If Pfizer does not wish to exercise its right to file any application for letters patent on patentable inventions relating to the Program Technology, then Pfizer shall provide Isis adequate written notice prior to any deadline with the U.S. Patent and Trademark Office or patent office of the [***] or [***], and Isis will have the right to prepare and file such application(s) at its sole expense. Isis will solely own all related patent applications and letters patent issuing therefrom and grant Pfizer a nonexclusive, non-transferable, irrevocable, worldwide, royalty-free, perpetual research license under its rights to such patent applications and letters patent.
(f) Pfizer shall notify Isis in a timely manner of any decision to abandon a pending application or an issued patent included in Program Technology Patent Rights. Thereafter, Isis shall have the option, at its expense, of continuing to prosecute any such pending patent application or of keeping the issued patent in force. Isis will own all related patent applications and letters patent issuing therefrom and grant Pfizer a nonexclusive, non-transferable, irrevocable, worldwide, royalty-free, perpetual r...
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Patent Rights in which Pfizer employees or consultants alone are named as inventors, Pfizer shall have those rights and duties ascribed to Gensia in Section 6.1. 6.3 Neither party may disclaim a Valid Claim within Patent Rights without the consent of the other. 7.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to Joint Patent Rights, Pfizer shall have those rights and duties ascribed to Icagen and Icagen shall have those rights and duties ascribed to Pfizer in Section 7.1 (but not the duties ascribed to Pfizer in Section 7.3), and Pfizer shall conduct such duties with in-house counsel of Pfizer or with counsel selected by Pfizer in its sole discretion, but after considering in good faith Icagen’s views with respect to such counsel.
FILING, PROSECUTION AND MAINTENANCE BY PFIZER. With respect to --------------------------------------------- Patent Rights in which Pfizer employees or consultants alone are named as inventors, Pfizer shall have those rights and duties ascribed to Megabios in Section 6.1; provided, however, that Pfizer shall be responsible for all costs.
